227
Views
0
CrossRef citations to date
0
Altmetric
Review

Diagnosis and Management of Neuropathic Pain

, , &
Pages 221-231 | Published online: 23 Jun 2014

References

  • Scadding JW . Treatment of neuropathic pain: historical aspects . Pain Med.5 ( Suppl. 1 ), S3 – S8 ( 2004 ).
  • Gordon AH . Clinical lecture on lead neuropath . Can. Med. Assoc. J.14 ( 6 ), 479 – 481 ( 1924 ).
  • Dyck PJ , LambertEH , O’BrienPC . Pain in peripheral neuropathy related to rate and kind of fiber degeneration . Neurology26 ( 5 ), 466 – 471 ( 1976 ).
  • Descriptions of chronic pain syndromes and definitions of pain terms . In:Classification of Chronic Pain (2nd Edition).MerskeyH , BogdukN (Eds.)IASP Press , Seattle, WA, USA ( 1994 ). 
  • Max MB . Clarifying the definition of neuropathic pain . Pain96 , 406 – 407 ( 2002 ).
  • Jensen TS , BaronR , HaanpääMet al. A new definition of neuropathic pain . Pain.152 , 2204 – 2205 ( 2011 ).
  • Bouhassira D , Lanteri-MinetM , AttalNet al. Prevalence of chronic pain with neuropathic characteristics in the general population . Pain136 , 380 – 387 ( 2008 ).
  • Taylor RS . Epidemiology of refractory neuropathic pain . World Inst. Pain6 ( 1 ), 22 – 26 ( 2006 ).
  • Torrance N , SmithBH , BennettMIet al. The epidemiology of chronic pain of predominantly neuropathic origin. Results from a general population study . J. Pain7 ( 4 ), 281 – 289 ( 2006 ).
  • Smith BH , TorranceN . Epidemiology of neuropathic pain and its impact on quality of life . Curr. Pain Headache Rep.16 , 191 – 198 ( 2012 ).
  • Partanan J , NiakanenL , LehitenJet al. Natural history of peripheral neuropathy in patients with non-insulin dependent diabetes mellitus . N. Engl. J. Med.333 , 88 – 94 ( 1995 ).
  • Dyck PJ , KratzKM , KarnesJLet al. The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort. The Rochester Diabetic Neuropathy Study . Neurology43 ( 4 ), 817 – 824 ( 1993 ).
  • Galil K , ChooPW , DonahueDVet al. The sequelae of herpes zoster . Arch. Intern. Med.157 , 1209 – 1213 ( 1997 ).
  • Kost RG , StrausSE . Postherpetic neuralgia – pathogenesis, treatment and prevention . N. Engl. J. Med.335 , 32 – 42 ( 1996 ).
  • Macrae WA . Chronic post-surgical pain: 10 years on . Br. J. Anaesth.101 , 77 – 86 ( 2008 ).
  • Andersen G , VestergaardK , Ingeman-NielsenM , JensenTS . Incidence of central post-stroke pain . Pain61 , 187 – 193 ( 1995 ).
  • Osterberg A , BoivieJ , ThuomasKA . Central pain in multiple sclerosis – prevalence and clinical characteristics . Eur. J. Pain9 , 531 – 542 ( 2005 ).
  • Finnerup NB , JohannesenIL , SindrupSH , BachFW , JensenTS . Pain and dysesthesia in patients with spinal cord injury: a postal survey . Spinal Cord39 , 256 – 262 ( 2001 ).
  • Bouhassira D , AttalN . Diagnosis and assessment of neuropathic pain: the saga of clinical tools . Pain152 , S74 – S83 ( 2011 ).
  • Bennett M . The LANSS Pain Scale: the Leeds assessment of neuropathic symptoms and signs . Pain92 , 147 – 157 ( 2001 ).
  • Cruccu G , SommerC , AnandPet al. EFNS guidelines on neuropathic pain assessment: revised 2009 . Eur. J. Neurol.17 , 1010 – 1018 ( 2010 ).
  • Attal N , BouhassiraD , BaronRet al. Assessing symptom profiles in neuropathic pain clinical trials: can it improve outcome? Eur. J. Neurol. 17 , 1113 – 1123 ( 2010 ).
  • Bennett MI , SmithBH , TorranceN , PetterJ . The S-LANSS score for identifying pain of predominantly neuropathic origin: validation for use in clinical and postal research . J. Pain6 , 149 – 158 ( 2005 ).
  • Backonja MM , KrauseSJ . Neuropathic pain questionnaire- short form . Clin. J. Pain19 , 315 – 316 ( 2003 ).
  • Bouhassira D . Neuropathic pain screening tools . In: Pain 2012: Refresher Courses, 14th World Congress on Pain.IreneTracey (Ed.) IASP Press , Seattle, WA , 123 – 129 ( 2012 ).
  • Porrenoy R . Development and testing of a neuropathic pain screening questionnaires: ID Pain . Curr. Med. Res. Opin.22 , 1555 – 1565 ( 2006 ).
  • Scholz J , MannionRJ , HordDEet al. A novel tool for the assessment of pain: validation in low back pain . PLoS Med.6 , e1000047 ( 2009 ).
  • Haanpää M , AttalN , BackonjaMet al. NeuPSIG guidelines on neuropathic pain assessment . Pain152 , 14 – 27 ( 2011 ).
  • Martinez-Lavin M , LopezS , MedinaM , NavaA . Use of the leeds assessment of neuropathic symptoms and signs questionnaire in patients with fibromyalgia . Semin. Arthritis Rheum.32 , 407 – 411 ( 2003 ).
  • Treede RD , JensenTS , CampbellJNet al. Redefinition of neuropathic pain and a grading system for clinical use: consensus statement on clinical and research diagnostic criteria . Neurology70 , 1630 – 1635 ( 2008 ).
  • Haanpää M , RowbothanM . Diagnosing neuropathic pain: clinical examination, neurophysiology, and neuroimaging . In: Pain 2012: Refresher Courses, 14th World Congress on Pain.IreneTracey (Ed.) IASP Press , Seattle, WA , 111 – 122 ( 2012 ).
  • Hansson P . Possibilities and potential pitfalls of combined bedside and quantitative somatosensory analysis in pain patients . In: Touch, Temperature, and Pain in Health and Disease: Mechanisms and Assessments.BoivieJ , HanssonP , LindblomU (Eds). IASP Press , Seattle, WA , 1 – 18 ( 1994 ).
  • Treede RD , JensenTS , CampbellJNet al. Neuropathic pain – redefinition and a grading system for clinical and research purposes . Neurology70 , 1631 – 1635 ( 2008 ).
  • Garcia- Larrea L . Refresher Courses of the 7th Congress of EFIC.European Federation of IASP , Seattle, WA, USA , 55 – 67 ( 2011 ).
  • Devigili G , TugnoliV , PenzaPet al. The diagnostic criteria for small fibre neuropathy: from symptoms to neuropathology . Brain131 , 1912 – 1925 ( 2008 ).
  • Crucco G , AnandP , AttalNet al. EFNS guidelines on neuropathic pain assessment . Eur. J. Neurol.11 , 153 – 162 ( 2001 ).
  • Rolke R , BaronR , MaierCet al. Quantitative sensory testing in the German Research Network on Neuropathic Pain (DFNS): standardized protocol and reference values . Pain123 , 231 – 243 ( 2006 ).
  • Chein A , EliavE , SterlingM . Whiplash (grade II) and cervical radiculopathy share a similar sensory presentation: an investigation using quantitative sensory testing . Clin. J. Pain24 , 595 – 603 ( 2008 ).
  • Backonja MM , WalkD , EdwardRRet al. Quantitative sensory testing in measurement of neuropathic pain phenomena and other sensory abnormalities . Clin. J. Pain7 , 641 – 647 ( 2009 ).
  • Walk D , SehgalN , Moeller-BertramTet al. Clin. J. Pain 7 , 632 – 640 ( 2009 ).
  • Torebjörk H-E . Human microneurography and intraneural microstimulation in the study of neuropathic pain . Muscle Nerve16 , 1063 – 1065 ( 1993 ).
  • Ochoa J , TorebjörkE . Sensations evoked by intraneural microstimulation of C nociceptor fibres in human skin nerves . J. Physiol.415 , 583 – 599 ( 1989 ).
  • Cruccu G , AminoffMJ , CurioGet al. Recommendations for the clinical use of somatosensory-evoked potentials . Clin. Neurophysiol.119 , 1705 – 1719 ( 2008 ).
  • Cruccu G , BiasiottaA , GaleottiF , IannettiGD , TruiniA , GronsethG . Diagnostic accuracy of trigeminal reflex testing in trigeminal neuralgia . Neurology66 , 139 – 141 ( 2006 ).
  • Cruccu G , GronsethG , AlksneJet al. AAN-EFNS guidelines on trigeminal neuralgia management . Eur. J. Neurol.15 , 1013 – 1028 ( 2008 ).
  • Truini A , GaleottiF , HaanpaaMet al. Pathoophysiology of pain in postherpetic neuralgia: a clinical and neurophysiological study . Pain140 , 405 – 410 ( 2008 ).
  • Sommer C , LauriaG . Skin biopsy in the management of peripheral neuropathy . Lancet Neurol.6 , 632 – 642 ( 2007 ).
  • Laura G , CornblathDR , JohanssonOet al. EFNS guidelines on the use of skin biopsy in the diagnosis of peripheral neuropathy . Eur. J. Neurol.12 , 747 – 758 ( 2005 ).
  • Miller TT , ReinusWR . Nerve entrapment syndromes of the elbow, forearm, and wrist . Am. J. Roentgenol.195 , 585 – 594 ( 2010 ).
  • Leitch JK , FigleyCR , StomanPW . Applying functional MRI to spinal cord and brainstem . Magn. Reson. Imaging28 , 1225 – 1233 ( 2010 ).
  • Iadarola MJ , MaxMB , BermanKFet al. Unilateral decrease in thalamic activity observed with positron emission tomography in patients with chronic neuropathic pain . Pain63 , 55 – 64 ( 1995 ).
  • Dworkin RH , TurkDC , FarrarJTet al. Core outcome measures for chronic pain clinical trials: IMMPACT recommendations . Pain113 , 9 – 19 ( 2005 ).
  • Magrinelli F , ZanetteG , TamburinSet al. Neuropathic pain: diagnosis and treatment . Pract. Neurol.13 ( 5 ), 292 – 307 ( 2013 ).
  • Dworkin RH , O’ConnorAB , BackonjaMet al. Pharmacological management of neuropathic pain: evidence-based recommendations . Pain132 , 237 – 251 ( 2007 ).
  • Attal N , CruccuG , BaronRet al. EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision . Eur. J. Neurol.17 , 1113 – 1123 ( 2010 ).
  • National Institute for Health and Care Excellence . Neuropathic Pain – Pharmacological Management. The Pharmacological Management of Neuropathic Pain in Adults in Non-Specialist Settings.National Institute for Health and Care Excellence , London, UK ( 2013 ).
  • O’Connor AB , DworkinRH . Treatment of neuropathic pain: an overview of recent guidelines . Am. J. Med.122 , S22 – S32 ( 2009 ).
  • Dworkin RH , O’ConnorAB , AudetteJet al. Recommendation for the pharmacological management of neuropathic pain: an overview and literature update . Mayo Clin. Proc.85 , S3 – S14 ( 2010 ).
  • Attal N , BennettMI , TreedeRD . Neuropathic pain update . In: IASP Refresher Course Lectures.IASP Press , Seattle, WA, USA , 85 – 129 ( 2012 ).
  • Goldstein DJ , LuY , DetkeMJet al. Duloxetine vs placebo in patients with painful diabetic neuropathy . Pain116 , 109 – 118 ( 2005 ).
  • Raskin J , PritchettYL , WangFet al. A double-blind, randomized multicenter trial comparing duloxetine with placebo in the management of diabetic peripheral neuropathic pain . Pain Med.6 , 346 – 356 ( 2005 ).
  • Rowbotham MC , GoliV , KunzNRet al. Venlafaxine extended release in the treatment of painful diabetic neuropathy; a double-blind, placebo-controlled study . Pain110 , 697 – 706 ( 2004 ).
  • Freeman R , Durso-DecruzE , EmirB . Efficacy, safety and tolerability of pregabalin treatment for painful diabetic peripheral neuropathy: findings from seven randomized controlled trials across a range of doses . Diabetes Care31 , 1448 – 1454 ( 2008 ).
  • Wiffen PJ , McQuayHJ , EdwardsJEet al. Gabapentin for acute and chronic pain . Cochrane Database Syst. Rev.3 , CD 005452 ( 2005 ).
  • Baron R , FreynhagenR , TooleTet al. The efficacy and safety of pregabalin in the treatment of neuropathic pain associated with lumbosacral radiculopathy . Pain150 , 420 – 427 ( 2010 ).
  • Zakrzewska JM . Insufficient evidence to recommend topical lidocaine as first-line treatment for postherpetic neuralgia . Evid. Based Dent.8 ( 3 ), 85 – 86 ( 2007 ).
  • Khaliq W , AlamS , PuriN . Topical Lidocaine for the treatment of postherpetic neuralgia . Cochrane Database Syst. Rev.18 , CD004846 ( 2007 ).
  • Finnerup NB , SindrupSH , JensenTS . The evidence for pharmacological treatment of neuropathic pain . Pain150 , 573 – 581 ( 2010 ).
  • Baron R , BinderA , WasnerG . Neuropathic pain: diagnosis, pathophysiological mechanisms, and treatment . Lancet Neurol.9 , 807 – 819 ( 2010 ).
  • Portenoy RK , FarrarJT , BackonjaMMet al. Long term use of controlled release oxycodone for noncancer pain: results of a 3-year registry study . Coin. J. Pain23 , 287 – 299 ( 2007 ).
  • Crofford LJ . Adverse effects of chronic opioid therapy for chronic musculoskeletal pain . Nat. Rev. Rheumatol.6 , 191 – 197 ( 2010 ).
  • Bril V , EnglandJ , FranklinGMet al. Evidence-based guideline: treatment of painful diabetic neuropathy: report of the American Academy of Neurology, the American Association of Neuromuscular and Electrodiagnostic Medicine and Rehabilitation . Neurology76 , 1758 – 1765 ( 2011 ).
  • Gilron I , BaileyJM , TuDet al. Nortriptyline and gabapentin, alone and in combination for neuropathic pain: a double-blind, randomized controlled crossover trial . Lancet374 , 1252 – 1261 ( 2009 ).
  • Gilron I , BaileyJM , TuDet al. Morphine, gabapentin, or their combination for neuropathic pain . N. Engl. J. Med.352 , 1324 – 1334 ( 2005 ).
  • Hanna M , O’BrienC , WilsonMC . Prolonged release oxycodone enhances the effects of existing gabapentin therapy in painful diabetic neuropathy patients . Eur. J. Pain12 , 804 – 813 ( 2008 ).
  • Tesfaye S , WilhelmS , LledoAet al. Duloxetine and pregabalin: high dose monotherapy or their combination? The “COMBO-DN study” – a multinational, randomized, double-blind parallel-group study in patients with diabetic peripheral neuropathic pain . Pain154 , 2616 – 2625 ( 2013 ).
  • Dorstyn D , MathiasJ , DensonL . Efficacy of cognitive behavior therapy for the management of psychological outcomes following spinal cord injury: a meta-analysis . J. Health Psychol.16 , 374 – 391 ( 2011 ).
  • Dworkin RH , O’ConnorAB , KentJet al. Interventional management of neuropathic pain: neuPSIG recommendations . Pain154 ( 11 ), 2249 – 2261 ( 2013 ).
  • Finnerup NB , ScholzJ , AttalNet al. Neuropathic pain needs classification . Eur. J. Pain17 , 953 – 956 ( 2013 ).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.